Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 234

Results For "gene"

2919 News Found

Lupin ties up with Foncoo of China
News | January 19, 2022

Lupin ties up with Foncoo of China

This is the company’s first partnership arrangement in China


Healthcare for seniors an opportunity for service providers
Public Health | January 19, 2022

Healthcare for seniors an opportunity for service providers

Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas


Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
People | January 19, 2022

Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences

He holds nine US patents and has published in multiple peer-reviewed journals and conferences


ICMR approves Krivida Novus RT-PCR kit
Medical Device | January 19, 2022

ICMR approves Krivida Novus RT-PCR kit

Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes


Menarini Diagnositcs PCR kit identifies Omicron variant
Medical Device | January 18, 2022

Menarini Diagnositcs PCR kit identifies Omicron variant

It provides Covid-19 detection and Omicron surveillance in less than two hours


Philips integrates cloud-based AI and 3D mapping into Zenition
Digitisation | January 18, 2022

Philips integrates cloud-based AI and 3D mapping into Zenition

New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment


Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology
News | January 18, 2022

Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology

Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines


DCGI approves Phase 3 clinical trial of Stempeucel to treat Covid-19 patients
Biotech | January 18, 2022

DCGI approves Phase 3 clinical trial of Stempeucel to treat Covid-19 patients

The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)


Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson injection
Drug Approval | January 17, 2022

Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson injection

The company has 47 ANDA's pending approval with the U.S.FDA


Green Valley receives US FDA approval for Phase II clinical trial for Parkinson’s disease
Biotech | January 17, 2022

Green Valley receives US FDA approval for Phase II clinical trial for Parkinson’s disease

The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period